|
The Motley Fool Discussion Boards
|
Previous Page | |
|
Industry Discussions / Biotechnology |
||
|
URL:
http://boards.fool.com/dsco-29894995.aspx
|
||
| Subject: dsco | Date: 3/7/2012 12:48 PM | |
| Author: shuksan77 | Number: 24826 of 24905 | |
|
Ah, my sad history, sort of, with DSCO. Which raises the daunting question of if and when to buy and sell biotechs. I bought and sold in 2001, made a little money. This was on the promise of Surfaxin. Nothing much happened. Bought and sold in 2003. Made a little money. Still on promise of Surfaxin. Nothing much happened--though the stock's price was a couple of bucks higher than it is now--even after approval. (Nothing to this,though, this often happens). 9-11 years later the cmpd gets the ok--after four tries--and the stock doesn't do much. One problem is that the addressable mkt isn't really that big--as these things go, so there is that. I guess the best bet is to await approval and commercialization in big markets. This reduces the biggest potential gains but prevents catastrophic failures... --S --WHo is still awaiting the best diet pill.... |
||
| Copyright 1996-2013 trademark and the "Fool" logo is a trademark of The Motley Fool, Inc. Contact Us | ||